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The nutrition of intracellular Mycobacterium tuberculosis is particularly experimentally intractable. In this
issue of Chemistry and Biology, using 13C labeling with a newmethod of data analysis, Beste and colleagues
provide direct evidence for the nutrients and pathways used by this ancient enemy of humanity.Intracellular bacterial pathogens inhabit
uniquely challenging environments inside
host cells and tissues. They must obtain
sufficient nutrients to survive and grow
by either adapting their own metabolic
pathways or manipulating themetabolism
of the host. Understanding the basic
biochemistry of these organisms in their
intracellular niches is vital to understand-
ing infection and related phenomena,
such as bacterial dormancy and pheno-
typic tolerance to antimicrobials. How-
ever, it is particularly difficult to measure
the nutrient availability and nutrient utili-
zation within the host.
The genome, enzymatic activities, and
growth characteristics in synthetic media
each indicate the metabolic potential of
bacteria, allowing the construction of a
biochemical roadmap. To measure the
actual reactions taking place in living
cells, stable-isotope (13C) labeled nutri-
ents can be fed to bacteria, where they
become incorporated into the metabo-
lome and biomass. Nuclear magnetic
resonance or mass spectrometry then
allow detection of the pattern of 13C pre-
sent in the bacteria. A technique called
metabolic flux analysis (MFA) combines
the 13C information during steady state
growth with an in silico model of central
carbon metabolism. Iterative fitting of
13C data to the model provides a solution
for the precise flux through each pathway
(the ‘‘traffic’’ along each mapped road)
that accounts for the observed pattern of
13C distribution (Zamboni et al., 2009).
Model organisms such as Escherichia
coli grown in synthetic medium have
been studied extensively by MFA. How-
ever, in the case of an intracellular
pathogen, the situation is more complex,
because the labeled carbon source has
to be taken up and potentially trans-
formed by the host before it becomes
available to the pathogen. With two inter-acting organisms, a steady state might
not be reached easily, and no attempts
at MFA have been made. Highlighting
the need to study intracellular pathogens
within host cells, transcriptome analysis
and gene knockout strategies indicate
that there are large differences in gene
expression between pathogens grown
in broth and cells, reflecting extensive
adaptation to intracellular life.
Although system-wide modeling of
intracellular growth had not previously
been attempted, 13C labeling of intra-
cellular pathogens has led to some impor-
tant insights into pathogen metabolism
within the host. A technique called 13C-
isotopologue profiling analysis (IPA)
compares 13C incorporation into host
and pathogen amino acids. Although flux
analysis is not carried out, this method
has nevertheless allowed the identifi-
cation of the nutrients used by three
intracellular human enteropathogens
(Eisenreich et al., 2010). Usually, a series
of mutants of the pathogen is needed to
make or validate the predictions.
In this way, glycerol, glucose-6-phos-
phate, and amino acids were identified
as carbon sources for Listeria monocyto-
genes in macrophages, whereas intra-
cellular Salmonella preferentially uses
glucose. Among the diversity of intra-
cellular pathogens, Mycobacterium
tuberculosis (Mtb) stands out as having
the largest impact on global health today
as well as indications from the genome
of a distinctive and extensive long chain
fatty acid metabolism.
Mtb is believed to utilize fatty acids
derived from host lipids and cholesterol,
because genes in the glyoxylate cycle
(isocitrate lysase) and gluconeogenesis
(phosphoenoylpyruvate carboxykinase)
are upregulated inside macrophages and
are essential for the infection of mice
(Marrero et al., 2010, Mun˜oz-Elı´as andChemistry & Biology 20, August 22, 2013McKinney, 2005, Schnappinger et al.,
2003). However, despite 130 years of
laboratory cultivation, direct evidence
was lacking. This is probably due to the
slow growth and need for biosafety level
3 containment, which would make the
comparison of multiple mutant strains by
IPA exceptionally laborious.
Beste and colleagues were the first to
tackle the metabolism of Mtb growing
on glycerol in vitro by MFA, establishing
a full model of central metabolism
(Beste et al., 2007, 2011). In this issue of
Chemistry & Biology, Beste et al. (2013)
report 13C glucose labeling of macro-
phages followed by infection with Mtb.
Macrophage and Mtb amino acids were
analyzed separately to produce a com-
plex data set. In a novel and innovative
approach that they call flux spectral
analysis, Beste et al. (2013) first analyzed
the 13C profile of macrophage amino
acids to deduce the 13C profile of carbon
sources within the macrophage. The 13C
profile of Mtb amino acids was then
analyzed by iterative fitting (similar to
MFA) to the in silico metabolic model
using combinations of one, two, or three
carbon sources from the macrophage.
This analysis is considerably more
sophisticated than any that has been
attempted for intracellular bacteria
previously.
Probably the most significant result of
the analysis is the direct evidence that
intracellular Mtb primarily utilize a C2
carbon source, which could be acetate
or acetyl CoA resulting from lipid degra-
dation, supporting the accumulation of
indirect evidence for a lipid diet. Unlike
other intracellular bacteria, which obtain
most amino acids from the host, Mtb
incorporates a select few host amino
acids into central carbon metabolism but
synthesizes the remainder of its amino
acids. This observation agrees with yearsª2013 Elsevier Ltd All rights reserved 971
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Previewof work on auxotrophic strains that are
able to grow in vitro but show reduced
or completely attenuated virulence in vivo.
Besides the likely lipid-derived carbon,
amino acids or an unidentified C3 carbon
source account for part of the 13C label-
ing. One of the surprising findings of
the MFA of Mtb in vitro was significant
incorporation of carbon derived from
carbon dioxide. In their latest work,
Beste et al. (2013) found that CO2 incor-
poration was even more significant inside
macrophages.
Their contribution to understanding
the biochemistry of intracellular Mtb
may help to explain the success of this
pathogen and may identify new drug
targets or aid the prioritization of exist-
ing drug targets, but it also opens up the
field for further investigation. Rapid intra-
cellular growth occurs in the acute phase972 Chemistry & Biology 20, August 22, 2013of Mtb infection, but the hallmarks of the
disease are chronic infection, periods of
clinical latency, and the requirement for
long treatment regimens. If the meta-
bolism of intracellularly growing Mtb
was mysterious, that of dormant Mtb is
even more elusive. Important insights
may come from using similar approaches
to study Mtb in environments that are
nonpermissive for growth, such as acti-
vated macrophages or hypoxic foamy
macrophages. Beste et al. have also
raised the bar for the study of other intra-
cellular pathogens, bringing system-wide
models of metabolic flux within reach.
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